First-line [18F]F-choline PET/CT in primary hyperparathyroidism: a cost-effectiveness study from the diagnostic randomized APACH2 trial
First-line FCH PET/CT in the surgical management of pHPT allows more patients to be referred directly to successful outpatient MIP at a minimal additional cost from a health insurance point of view.
Authors
- Marie Cavarec
- Jean‐Michel Grellard (ORCID: https://orcid.org/0000-0001-7997-5027)
- Lawrence Nadin
- Bénédicte Clarisse (ORCID: https://orcid.org/0000-0002-0543-732X)
- Célia Berchi (ORCID: https://orcid.org/0000-0002-3091-8539)
- Elske Quak (ORCID: https://orcid.org/0000-0003-0791-9899)
- F. Jégoux (ORCID: https://orcid.org/0000-0001-9370-3490)
- Clémence Guery
- Guy Thomas
- Audrey Lasne-Cardon
Institutions
- Université Rennes 2 (FR)
- Centre François Baclesse (LU)
- Centre Eugène Marquis (FR)
- Centre François Baclesse (FR)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Université de Rennes (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1007/s00259-025-07728-8
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 34.94
Funders
- Ligue Contre le Cancer
- Institut National Du Cancer
- National Cancer Institute